MedTrace Logo

Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis

NCT02408471 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2023-10-10

Study results available
· View outcomes & findings →

Summary

This study is a non-randomized, consecutive enrollment, one-year post-approval study of patients who are treated with the Ascension® MCP.

Conditions

Interventions

DEVICE

Ascension® MCP Finger Implant

Patients who meet inclusion/ exclusion criteria are treated with the Ascension® MCP.

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew Tummon · Sponsor- Integra LifeSciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02408471 on ClinicalTrials.gov